Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Apr, 2014 | Pages:
40 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
BioDelivery Sciences International, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'BioDelivery Sciences International, Inc. - Product Pipeline Review - 2014', provides an overview of the BioDelivery Sciences International, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of BioDelivery Sciences International, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of BioDelivery Sciences International, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of BioDelivery Sciences International, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the BioDelivery Sciences International, Inc.'s pipeline products Reasons to buy - Evaluate BioDelivery Sciences International, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of BioDelivery Sciences International, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the BioDelivery Sciences International, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of BioDelivery Sciences International, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of BioDelivery Sciences International, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of BioDelivery Sciences International, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 BioDelivery Sciences International, Inc. Snapshot 5 BioDelivery Sciences International, Inc. Overview 5 Key Information 5 Key Facts 5 BioDelivery Sciences International, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 BioDelivery Sciences International, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Combination Treatment Modalities 10 Pipeline Products - Out-Licensed Products 11 Out-Licensed Products/Combination Treatment Modalities 12 BioDelivery Sciences International, Inc. - Pipeline Products Glance 13 BioDelivery Sciences International, Inc. - Late Stage Pipeline Products 13 Pre-Registration Products/Combination Treatment Modalities 13 Phase III Products/Combination Treatment Modalities 14 BioDelivery Sciences International, Inc. - Early Stage Pipeline Products 15 IND/CTA Filed Products/Combination Treatment Modalities 15 Preclinical Products/Combination Treatment Modalities 16 BioDelivery Sciences International, Inc. - Drug Profiles 17 (buprenorphine + naloxone) 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 fentanyl citrate 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 clonidine hydrochloride 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 granisetron 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 BEMA Triptan 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 BioDelivery Sciences International, Inc. - Pipeline Analysis 23 BioDelivery Sciences International, Inc. - Pipeline Products by Target 23 BioDelivery Sciences International, Inc. - Pipeline Products by Route of Administration 25 BioDelivery Sciences International, Inc. - Pipeline Products by Molecule Type 26 BioDelivery Sciences International, Inc. - Pipeline Products by Mechanism of Action 27 BioDelivery Sciences International, Inc. - Recent Pipeline Updates 29 BioDelivery Sciences International, Inc. - Dormant Projects 33 BioDelivery Sciences International, Inc. - Discontinued Pipeline Products 34 Discontinued Pipeline Product Profiles 34 amphotericin B 34 BioDelivery Sciences International, Inc. - Company Statement 35 BioDelivery Sciences International, Inc. - Locations And Subsidiaries 38 Head Office 38 Other Locations & Subsidiaries 38 Appendix 39 Methodology 39 Coverage 39 Secondary Research 39 Primary Research 39 Expert Panel Validation 39 Contact Us 40 Disclaimer 40
List of Tables BioDelivery Sciences International, Inc., Key Information 5 BioDelivery Sciences International, Inc., Key Facts 5 BioDelivery Sciences International, Inc. - Pipeline by Indication, 2014 7 BioDelivery Sciences International, Inc. - Pipeline by Stage of Development, 2014 8 BioDelivery Sciences International, Inc. - Monotherapy Products in Pipeline, 2014 9 BioDelivery Sciences International, Inc. - Combination Treatment Modalities in Pipeline, 2014 10 BioDelivery Sciences International, Inc. - Out-Licensed Products in Pipeline, 2014 11 BioDelivery Sciences International, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 12 BioDelivery Sciences International, Inc. - Pre-Registration, 2014 13 BioDelivery Sciences International, Inc. - Phase III, 2014 14 BioDelivery Sciences International, Inc. - IND/CTA Filed, 2014 15 BioDelivery Sciences International, Inc. - Preclinical, 2014 16 BioDelivery Sciences International, Inc. - Pipeline by Target, 2014 24 BioDelivery Sciences International, Inc. - Pipeline by Route of Administration, 2014 25 BioDelivery Sciences International, Inc. - Pipeline by Molecule Type, 2014 26 BioDelivery Sciences International, Inc. - Pipeline Products by Mechanism of Action, 2014 28 BioDelivery Sciences International, Inc. - Recent Pipeline Updates, 2014 29 BioDelivery Sciences International, Inc. - Dormant Developmental Projects,2014 33 BioDelivery Sciences International, Inc. - Discontinued Pipeline Products, 2014 34 BioDelivery Sciences International, Inc., Subsidiaries 38
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
